Analyze Biotech Private Limited, a active private limited company, was established on 01 December 2011 in Viluppuram, Tamil Nadu, India. Engaging in other hospital and medical care activities within the hospital and medical care sector, it holds CIN: U74900TN2011PTC083398. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.
Formerly known as Analyzing Biotech Private Limited. It upholds a active non-compliant status. Its leadership includes Sundaracholavarma Singaravelu (Director), Subramani Jaiganesh (Director). Past directors included Saravanan Pushpanathan, Subramani Manikandan. It holds ₹3.66 M open charges and ₹3.66 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 1/51, Barathiyar Street, Viluppuram, Tamil Nadu, 605601.
U32509TN2011PTC083398
083398
01 December 2011
₹1.00 M
₹0.50 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Analyze Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sundaracholavarma Singaravelu | Director | 29 Aug 2016 | Current |
| Subramani Jaiganesh | Director | 01 Dec 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Director | 29 Aug 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Analyze Biotech Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Analyze Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,660,000.00
₹3,660,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Nov 2017 | The South Indian Bank Limited | ₹3.66 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Analyze Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Analyze Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Analyze Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 01 Nov 2017 via Charge ID 100159320 with The South Indian Bank Limited was fully satisfied on 21 Nov 2025. was completed.
The activity Analyze Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
The activity Analyze Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was completed.
A charge with The South Indian Bank Limited of Rs. 3.66 M registered on 01 Nov 2017 with Charge ID 100159320 was modified on 11 Jun 2020. was recorded as a recent event.
Progress on A charge with The South Indian Bank Limited amounted to Rs. 3.66 M with Charge ID 100159320 was registered on 01 Nov 2017. was documented.
Progress on Sundaracholavarma Singaravelu was appointed as a Director was appointed as a Director on 29 Aug 2016 & has been associated with this company since 9 years 4 months . was documented.
The CIN of Analyze Biotech Private Limited is U32509TN2011PTC083398.
Analyze Biotech Private Limited is headquartered at 1/51, Barathiyar Street, Viluppuram, Tamil Nadu, 605601.
Analyze Biotech Private Limited was incorporated on 01 December 2011.
The current directors of Analyze Biotech Private Limited are
The primary industry of Analyze Biotech Private Limited is Hospital And Medical Care.
Analyze Biotech Private Limited is unlisted.
The authorized capital of Analyze Biotech Private Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.
The compliance status of Analyze Biotech Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX